실리콘밸리 2012년 4분기 벤처투자리스트

Click here to load reader

  • date post

    21-Oct-2014
  • Category

    Business

  • view

    449
  • download

    11

Embed Size (px)

description

실리콘밸리 2012년 4분기 벤처투자리스트.

Transcript of 실리콘밸리 2012년 4분기 벤처투자리스트

Venture Capital Funding Survey, Fourth Quarter 2012

VENTURE CAPITAL FUNDING, FOURTH QUARTER 2012

This is a listing of many of the Bay Area firms that received venture capital financing between

Oct. 1 and Dec. 31, 2012. Most of the data was compiled from a survey conducted by

PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association in

conjunction with the Mercury News.

In the case of some investments there may have been other participants in the round who are not

credited. Also, the amounts listed may not include all venture funding the company received during

the quarter.

*Indicates this is a seed or first-round infusion of money from venture capitalists. These

companies may have received money previously from other investors and aren't necessarily startups.

BIOTECHNOLOGY / HEALTH

Name City Stage Amount Investors Business Description

3-V Biosciences Menlo Park Early Stage $8,089,000

Kleiner Perkins Caufield &

Byers, New Enterprise

Associates

Biopharmaceutical

company

Access Closure Mountain View Later Stage $998,100

New Leaf Venture Partners,

ONSET Ventures, Three Arch

Partners

Distributes vascular

closure devices

Advanced Cell Diagnostics Hayward Expansion $12,000,000

Morningside Venture

Investments, New Leaf

Venture Partners

Cell- and tissue-based

diagnostic tests

Adynxx San Francisco Early Stage $2,000,000 Domain Associates

Clinical-stage

pharmaceutical company

Afferent Pharmaceuticals San Mateo Early Stage $5,000,000

Domain Associates, Pappas

Ventures

Clinical-stage

biopharmaceutical

company

Allakos* San Mateo Early Stage $10,000,000

Alta Partners, De Novo

Ventures, F. Hoffmann-La

Roche AG, RiverVest Venture

Partners Biotechnology company

Articulinx Cupertino Early Stage $2,200,000 US Venture Partners

Implant system for

osteoarthritis

Calcula Technologies* San Francisco Startup/Seed $1,500,000

Band of Angels, undisclosed

firm Urological medical device

Calithera Biosciences

South San

Francisco Early Stage $2,000,000

Advanced Technology

Ventures, Delphi Ventures,

Morgenthaler Ventures Therapeutics company

Carbylan Biosurgery Palo Alto Early Stage $6,000,000

Alta Partners, InterWest

Partners, Vivo Ventures Surgical devices

Page 1 of 19

Venture Capital Funding Survey, Fourth Quarter 2012

CardioDx Palo Alto Later Stage $5,998,000

Kleiner Perkins Caufield &

Byers, Longitude Capital

Associates, Pappas Ventures

Genomic diagnostics

company

Cell Works Group Saratoga Expansion $13,000,000 Artiman Ventures

Life sciences technology

company

Cerephex* Los Gatos Early Stage $5,924,000

CHV Capital, H.I.G. Capital,

Versant Ventures Medical device company

Ceterix Orthopedics Menlo Park Early Stage $19,500,000

5AM Ventures, Versant

Ventures Medical device company

Chronix Biomedical San Jose Later Stage $1,415,000 PrairieGold Venture Partners

Approach to the diagnosis,

management of range of

cancers

Cobalt Technologies Mountain View Expansion $4,977,000

Burrill & Co, Life Sciences

Partners BV, Pinnacle

Ventures

Produces renewable

biobutanol

Cotera* Menlo Park Startup/Seed $5,041,000

Domain Associates, Foundry,

Versant Ventures

Medical equipment and

supplies manufacturing

company

Crescendo Bioscience

South San

Francisco Later Stage $28,454,000

Aeris Capital AG, Kleiner

Perkins Caufield & Byers, Mohr

Davidow Ventures, Safeguard

Scientifics, Skyline Ventures,

undisclosed firm

Molecular diagnostics

company

Edison Pharmaceuticals* Mountain View Early Stage $20,050,000 Mitsui & Co. Global Investment

Treatments for children

with orphan mitochondrial

diseases

Eve Biomedical Mountain View Early Stage $6,003,000

Draper Fisher Jurvetson

International Inc, undisclosed

firm Biotechnology company

Fluxion Biosciences

South San

Francisco Expansion $2,000,000

Kodiak Venture Partners,

undisclosed firm Cellular analysis tools

Igenica Burlingame Early Stage $10,250,000

5AM Ventures, Column Group,

The OrbiMed Advisors, Third

Rock Ventures

Therapeutics for the

treatment of cancer

Intarcia Therapeutics Hayward Later Stage $155,898,000

Alta Partners, Farallon Capital

Management, New Enterprise

Associates, New Leaf Venture

Partners, undisclosed firms,

Venrock

Biopharmaceutical

company

Page 2 of 19

Venture Capital Funding Survey, Fourth Quarter 2012

IntegenX Pleasanton Later Stage $9,400,000

Domain Associates, Essex

Woodlands Health Ventures,

Latterell Venture Partners LP,

QuestMark Partners Microfluidic systems

Irhythm Technologies San Francisco Expansion $1,500,000 Undisclosed firm

Markets diagnostic

monitoring solutions

Labrys Biologics* San Francisco Early Stage $14,588,100

Canaan Partners, InterWest

Partners, Sofinnova Ventures Biotechnology company

Linkage Biosciences San Francisco Expansion $1,545,000 Greenhouse Capital Partners

Molecular diagnostic

products for genetic testing

Mature Women's Health

Solutions* Los Gatos Early Stage $6,000,000

Canaan Partners, HealthTech

Capital Products and services

Minerva Surgical Cupertino Early Stage $20,000,000 Versant Ventures Medical device company

Nanostim Sunnyvale Early Stage $9,999,900

Emergent Medical Partners,

InterWest Partners, US

Venture Partners Cardiac pacemaker

NextWave Pharmaceuticals Cupertino Expansion $1,819,000 Sofinnova Ventures

Specialty pharmaceutical

company

Oculeve* San Francisco Early Stage $7,565,000

Kleiner Perkins Caufield &

Byers, New Enterprise

Associates, undisclosed firm Treatment for dry eye

Optimedica Sunnyvale Later Stage $35,000,000

Alloy Ventures, Bio*One

Capital Pte., BlackRock Private

Equity Partners, Duff

Ackerman & Goodrich, Kleiner

Perkins Caufield & Byers

Ophthalmic device

company

Pearl Therapeutics Redwood City Early Stage $23,273,200

5AM Ventures, Clarus

Ventures, New Leaf Venture

Partners, Vatera Healthcare

Partners

Therapies for the treatment

of respiratory diseases

Penumbra Alameda Later Stage $121,000 Undisclosed firm Medical device company

Presidio Pharmaceuticals San Francisco Early Stage $7,977,900

Baker Bros Advisors, New Leaf

Venture Partners, Panorama

Capital

Pharmaceutical company

on infections

Relypsa Redwood City Early Stage $2,600,100

5AM Ventures, New Leaf

Venture Partners, OrbiMed

Advisors

Clinical-stage

biopharmaceutical

company

Page 3 of 19

Venture Capital Funding Survey, Fourth Quarter 2012

SFJ Pharmaceuticals Pleasanton Expansion $500,000

Clarus Ventures, undisclosed

firm Pharmaceutical company

Solstice Biologics* San Francisco Startup/Seed $10,500,000

Aeris Capital AG, venBio

Partners Nucleic acid therapeutics

Trireme Medical Pleasanton Expansion $18,000,000 Undisclosed firms Medical device company

TriVascular Santa Rosa Later Stage $24,600,000 MPM Capital, undisclosed firm Endovascular grafts

Ultragenyx Pharmaceutical Novato Early Stage $75,000,200

BlackRock Private Equity

Partners, Fidelity Biosciences,

HealthCap Partners, Pappas

Ventures, TPG Growth,

undisclosed firms

Treatments for rare and

ultra-rare genetic disorders

VeraCyte

South San

Francisco Expansion $14,950,000

Domain Associates, Kleiner

Perkins Caufield & Byers

Molecular tests for the

diagnostics company

BUSINESS SERVICESName City Stage Amount Investors Business Description

adRise* San Francisco Early Stage $2,016,000

Foundation Capital,

undisclosed firm

Connected television

advertising applications

AirPR* San Francisco Startup/Seed $1,000,000

500 Startups, Correlation

Ventures, Crosslink Capital,

Mohr Davidow Ventures,

undisclosed firm

Technology platform to

increase PR performance

Axcient Mountain View Expansion $5,000,000 Scale Venture Partners

On-demand data protection

services

Balanced* Palo Alto Early Stage $1,400,000 SV Angel, undisclosed firm

Payments, escrow and

disbursement platform

Cloud Engines San Francisco Expansion $2,500,000 SoftBank Capital

Personal cloud hardware

and software

FreeWheel Media San Mateo Expansion $8,250,000

Battery Ventures, Foundation

Capital, Steamboat Ventures,

undisclosed firm

Business support services

to media companies